BSE filing, NSE: STARTECK. Summary written from the filing by ALFA Finder's alert engine.
Starteck Finance Ltd: key numbers
- Share price
- ₹248.70
- Market cap
- ₹246.5 Cr
- Revenue (annual)
- ₹35.76 Cr
- Net profit (annual)
- ₹23.61 Cr
- P/E (TTM)
- 10.1×Sector 19.7×
- Promoter holding
- 73.30%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Starteck Finance Ltd
All →Starteck Finance Price Movement Clarification
Starteck Finance Limited clarified that there is no undisclosed material information impacting recent stock price movements. The company remains compliant with all SEBI disclosure regulations.
Starteck Finance Annual General Meeting
Starteck Finance Limited held its 41st Annual General Meeting on September 18, 2026, where members voted on eight resolutions including financial adoption and dividend declaration.
Starteck Finance Annual General Meeting
Starteck Finance issued an addendum to its 41st AGM notice. The update adds the re-appointment of Mr. Nilesh Parikh as an Independent Director to the agenda.
Starteck Finance Management Change
Starteck Finance has re-appointed Mr. Nilesh Parikh as an Independent Director for a second five-year term, effective September 6, 2026, subject to shareholder approval.
Starteck Finance Annual General Meeting
Starteck Finance Limited has scheduled its 41st Annual General Meeting for 18th September, 2026. The company has fixed 11th September, 2026, as the record and cut-off date.
Starteck Finance Q1 FY27 Results: Net Profit ₹4.3 Cr, Up 22.9% YoY
Starteck Finance Ltd reported revenue from operations of ₹10.9 Cr (+39.7% YoY) and net profit of ₹4.3 Cr (+22.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹4.3 Cr · +22.9% YoY
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.